Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RN7SK pseudogene 128 (RN7SKP128)** is a pseudogene related to **RN7SK**, an RNA gene that encodes the RNA component of the 7SK small nuclear ribonucleoprotein (snRNP)[1]. RN7SK itself is a well-studied non-coding RNA that acts as a central scaffold for the 7SK snRNP complex, playing a key regulatory role in controlling transcription elongation by RNA polymerase II[2][3]. However, RN7SKP128 is classified as a pseudogene, meaning it does not encode a functional RNA or protein and is typically not considered to have a direct biological function, disease association, or therapeutic relevance[1]. There is no evidence in authoritative databases that RN7SKP128 is a receptor, enzyme, transporter, or therapeutic target, and it should not be confused with the functional RN7SK small nuclear RNA[1][5]. **Key notes:** - RN7SKP128 is a **pseudogene** (a non-functional genetic element) and does not correspond to a protein, receptor, enzyme, or molecular target used in therapeutics. - There is a similarly named functional gene, RN7SK, which is a non-coding RNA but this is NOT what is meant by RN7SKP128[3]. - Pseudogenes like RN7SKP128 are typically not classified under molecular target families such as "Receptor," "Enzyme," or "Transcription factor" nor are they directly implicated in biological functions or disease processes[1]. If you are seeking a legitimate therapeutic target or receptor, RN7SKP128 is not valid; however, RN7SK (the functional RNA) may be of biological interest[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 128 (RN7SKP128).